A Study of Efficacy and Safety of Telbivudine in Pregnancy for the Prevention of Perinatal Transmission of Hepatitis B HeVirus Infection.

Trial Profile

A Study of Efficacy and Safety of Telbivudine in Pregnancy for the Prevention of Perinatal Transmission of Hepatitis B HeVirus Infection.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Sep 2015

At a glance

  • Drugs Telbivudine (Primary)
  • Indications Hepatitis B
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Nov 2010 Results were presented at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (Abstract No. 212), according to an AASLD media release.
    • 01 Nov 2010 Primary endpoint 'Infection-rate' has been met, according to abstract presented at AASLD.
    • 01 Nov 2010 Results were presented at the 61st Annual Meeting of the American Association for the Study of Liver Diseases.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top